Resonant Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.1M Buy
31,697
+521
+2% +$61K 0.2% 86
2026
Q1
$3.77M Buy
31,176
+17,614
+130% +$2.03M 0.2% 82
2025
Q4
$1.44M Buy
13,562
+1,059
+8% +$99.4K 0.08% 140
2025
Q3
$1.06M Buy
12,503
+1,041
+9% +$85.7K 0.06% 160
2025
Q2
$916K Buy
11,462
+1,396
+14% +$111K 0.06% 167
2025
Q1
$910K Buy
10,066
+1,111
+12% +$104K 0.06% 156
2024
Q4
$898K Sell
8,955
-397
-4% -$40.9K 0.07% 157
2024
Q3
$1.07M Buy
9,352
+217
+2% +$25.8K 0.08% 147
2024
Q2
$1.14M Buy
9,135
+1,353
+17% +$174K 0.09% 133
2024
Q1
$1.03M Buy
7,782
+1,389
+22% +$171K 0.09% 138
2023
Q4
$702K Buy
6,393
+112
+2% +$11.6K 0.07% 161
2023
Q3
$651K Buy
6,281
+63
+1% +$6.79K 0.07% 151
2023
Q2
$722K Buy
6,218
+76
+1% +$8.63K 0.08% 144
2023
Q1
$658K Sell
6,142
-958
-13% -$103K 0.07% 149
2022
Q4
$792K Buy
7,100
+1,322
+23% +$135K 0.1% 131
2022
Q3
$502K Buy
5,778
+270
+5% +$24.1K 0.08% 150
2022
Q2
$506K Buy
5,508
+434
+9% +$38.5K 0.08% 153
2022
Q1
$427K Buy
5,074
+476
+10% +$37.5K 0.06% 151
2021
Q4
$355K Buy
4,598
+1,120
+32% +$89.2K 0.05% 160
2021
Q3
$263K Buy
+3,478
New +$265K 0.05% 170
2020
Q2
Sell
-3,887
Closed -$285K 183
2020
Q1
$285K Sell
3,887
-412
-10% -$32.4K 0.1% 156
2019
Q4
$373K Buy
+4,299
New +$353K 0.12% 160

Other funds holding MRK

Resonant Capital Advisors's MRK Position: Q2 2026 in Review

Resonant Capital Advisors increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $61K and bringing the position to 31,697 shares worth $4.1M. The position accounts for 0.2% of the portfolio, ranked #86.

Resonant Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 22 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Resonant Capital Advisors held 31,697 shares of Merck worth $4.1M as of Q2 2026.
  • Resonant Capital Advisors bought 521 Merck shares in Q2 2026, an estimated $61K.
  • Merck made up 0.2% of Resonant Capital Advisors's portfolio in Q2 2026, its #86 holding.
  • Resonant Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 22 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.